Xvivo Perfusion AB (0RKL.LSE) Q1 2024 Earnings

Apr 24Confirmed
Q1 2024
0.4
0.52
0.64
0.77

Details

Expected EPS
0.396311557295
Actual EPS
0.7673803402400001
Surprise EPS
0.37
Surprise Percent
+93.63%

Description

⁨Xvivo Perfusion AB⁩ (⁦0RKL.LSE⁩) has reported earnings of ⁦0.7673803402400001⁩ per share for ⁦Q1 2024⁩.

0 Comments

Share your thoughts